Vulvodynia, "A Really Great Torturer": A Mixed Methods Pilot Study Examining Pain Experiences and Drug/Non-drug Pain Relief Strategies
Overview
Reproductive Medicine
Urology
Authors
Affiliations
Background: Women with vulvodynia, a chronic pain condition, experience vulvar pain and dyspareunia. Few studies examine the range and combination of treatment strategies that women are actually using to reduce vulvodynia.
Aim: To describe pain experiences and pain relief strategies of women with vulvodynia.
Methods: Convenience sample, 60 women with vulvodynia (median age 32.5 [interquartile range {IQR} 8.5] years; 50 white, 10 racial/ethnic minorities) completed PAINReportIt and reported use of drugs and alcohol and responded to open-ended questions. Univariate descriptive statistics and bivariate inferential tests were used to describe average pain intensity scores, alcohol use, smoking, number of pain relief strategies, and their associations. Women's open-ended responses about their pain experiences and drug and non-drug pain relief strategies (NDPRS) were analyzed for patterns.
Outcomes: Our mixed methods analysis connected data from pain measures, prescribed treatments and self-reported behaviors with women's free responses. This enabled nuanced insights into women's vulvodynia pain experiences.
Results: Women's descriptions of their pain and suffering aligned with their reported severe pain and attempts to control their pain, with a median pain intensity of 6.7 (IQR 2.0) despite use of adjuvant drugs (median 2.0 [IQR 2.0]), and opioids (median 1.0 [IQR 2.0]). 36 women (60%) used alcohol to lessen their pain. 26 women (43%) listed combining analgesics and alcohol to relieve their pain. 30 women (50%) smoked cigarettes. 54 women (90%) used ≥1 NDPRS. The mean number of NDPRS used was 2.1 ± 1.3 (range 0-6). The 5 most common NDPRS from women's comments were herbal medicine (40%), acupuncture (27%), massage (22%), hypnosis (15%), and mental healthcare (13%).
Clinical Implications: Severe pain in women with vulvodynia may be a clinical indicator of those at higher risk of combining prescription pain medications with alcohol, which are all central nervous system depressants and may potentiate overdose.
Strengths And Limitations: This pilot study demonstrated that the mixed methods approach to help understand the complexity of vulvodynia was feasible. We identified data showing a reliance on a high-risk mix of prescriptions and alcohol to reduce vulvodynia pain and a high prevalence of cigarette smoking. However, as a pilot study, these results are considered preliminary; the sample may not be representative. Perhaps only women at the extreme end of the pain continuum participated, or women took the survey twice because identifiers were not collected.
Conclusion: Despite attempts to reduce pain using multiple therapies, including alcohol, women's vulvodynia pain is severe and not controlled. Schlaeger JM, Pauls HA, Powell-Roach KL, et al. Vulvodynia, "A Really Great Torturer": A Mixed Methods Pilot Study Examining Pain Experiences and Drug/Non-drug Pain Relief Strategies. J Sex Med 2019;16:1255-1263.
Ventura-Aquino E, Paredes R Front Behav Neurosci. 2023; 17:1184897.
PMID: 37840548 PMC: 10568070. DOI: 10.3389/fnbeh.2023.1184897.
Evaluation and Treatment of Vulvodynia: State of the Science.
Schlaeger J, Glayzer J, Villegas-Downs M, Li H, Glayzer E, He Y J Midwifery Womens Health. 2022; 68(1):9-34.
PMID: 36533637 PMC: 10107324. DOI: 10.1111/jmwh.13456.
Desloge A, Patil C, Glayzer J, Suarez M, Kobak W, Meinel M J Integr Complement Med. 2022; 29(1):50-54.
PMID: 36130137 PMC: 9917314. DOI: 10.1089/jicm.2022.0647.
Image-based documentation of vulvodynia pain location.
Telisnor G, Garg R, Glayzer J, Kobak W, Kiros G, Yao Y Pain Manag. 2022; 12(4):417-424.
PMID: 35060761 PMC: 8981421. DOI: 10.2217/pmt-2021-0110.
Glayzer J, McFarlin B, Castori M, Suarez M, Meinel M, Kobak W Am J Med Genet C Semin Med Genet. 2021; 187(4):599-608.
PMID: 34747110 PMC: 8665058. DOI: 10.1002/ajmg.c.31939.